Business Wire

PA-THE-COHESIVE

30.11.2022 22:04:44 CET | Business Wire | Press release

Share
Digital Integrator Cohesive Group Acquires Vetasi, Leading Provider of IBM Maximo Managed Services

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced that its Cohesive Group digital integrator business has acquired Vetasi, a leading international consultancy specializing in enterprise asset management (EAM) solutions, with a strong focus on IBM Maximo.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130006068/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Image courtesy - Getty Images

Vetasi brings to Cohesive the largest IBM Maximo consultancy team across Europe, Africa, and ASEAN countries, with headquarters in the United Kingdom and operations based in Poland, Indonesia, South Africa, Spain, Ukraine, and Australia. In addition to EAM resources, Vetasi deepens the Cohesive team with additional strategic advisory capabilities and adds to the Cohesive services catalog Maximo cloud hosting capabilities, expertise in low-code development, and strong real estate and facilities management domain knowledge. By virtue of the combination with Cohesive, Vetasi’s clients can benefit from the multidiscipline scope of a world-leading digital integrator, combining greater global scale with local agility to leverage more value from their asset portfolios.

Cohesive was founded by Bentley in 2020 as a digital engineering systems integrator to help infrastructure owner-operators deliver transformational and sustainable outcomes. Cohesive has achieved consistent significant growth and continues to win substantial new projects, notably in the utilities, transport, and energy sectors. Prior to Vetasi, Cohesive has acquired multiple organizations in the EAM and digital twin advisory space to increase service delivery capacity, including prioritizing geographical reach for significantly growing opportunities in the EMEA and especially Asia Pacific regions.

David Hollister, Bentley Systems’ chief investment officer, said, “The acquisition of Vetasi, with over 200 colleagues in EMEA and Asia Pacific, contributes substantially towards our objectives for Cohesive as an independent digital integrator, largely filling any remaining gaps to achieve comprehensive global self-sufficiency and economies of scale across the full lifecycle of infrastructure assets. Additionally, Vetasi significantly accelerates Cohesive’s learning curve in cloud hosting provisioning for Maximo. Cohesive’s growing success will show the way for engineering firms to create and curate digital twin data-centric cloud services for infrastructure owner-operators, increasing opportunities for Bentley’s market-leading iTwin Platform.”

Mark Bew, CEO of Cohesive, said, “Acquiring Vetasi enables Cohesive to consolidate its position as a global leader in digital engineering systems integration. This significantly scales out our global platform to build long-term, high-value partnerships with our clients. By advancing Maximo implementations to function within digital “infinity twins,” Cohesive can help to transform asset-owners’ businesses from an operational perspective while also improving their ESG performance. On behalf of Cohesive’s talent force of now over 700 colleagues everywhere, we warmly embrace the Vetasi team and look forward to the next step in our shared journey.”

Jarosław Łukasiewicz, CEO of Vetasi, who joins Cohesive along with other executive partners James Fair and Trevor Roberts, said, “We are delighted to join Cohesive and contribute to its mission of delivering transformational and sustainable outcomes through the built and natural environment. Becoming part of Cohesive enables us to expand our partnerships with our clients and build further upon Vetasi’s vision of delivering solutions that deliver real value.”

Image 1:
Getty Images

##

About Cohesive

As a world-class digital engineering systems integrator and consultancy, Cohesive partners with infrastructure asset owner-operators and enterprise leaders to design and deliver transformational outcomes in both the built and natural environments, achieving for its clients practical service and financial and social goals. Its portfolio of industry and implementation experts, lifecycle capabilities, and key software proficiencies enables Cohesive to support and improve the most complex infrastructure projects and assets globally.

Learn more at https://cohesivegroup.com.

About Bentley Systems

Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geoprofessional software portfolio, and the iTwin Platform for infrastructure digital twins. Bentley Systems employs more than 4,500 colleagues and generates annual revenues of approximately $1 billion in 186 countries.
www.bentley.com

© 2022 Bentley Systems, Incorporated. Bentley, AssetWise, Cohesive, iTwin, MicroStation, ProjectWise, Seequent, and Vetasi are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130006068/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye